Sponsor

Hookipa Biotech GmbH

Clinical research sponsor

Published trials2

Recruiting shown0

Roles1

SourceClinicalTrials.gov

Clinical trials

2 shown

Safety, Reactogenicity and Immunogenicity of HB-502 and HB-501 Versus Placebo in People With HIV on Suppressive ARTNCT06430905 · lead sponsor · 2024-07-01

TERMINATED

HB-302/HB-301 Therapy in Participants With Metastatic Castration-Resistant Prostate CancerNCT05553639 · lead sponsor · 2023-05-23

TERMINATED

Sponsor roles

lead sponsor2

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.